The pharmaceutical company, GlaxoSmithKline (GSK), has insisted that there is no risk to patients despite its decision to recall two drugs from wholesalers, following concerns at its Cork plant.

The decision was made after an investigator from the US Food and Drug Administration (FDA) found that a drug ingredient - paroxetine - was contaminated with material from the Cork plant's pharmaceutical waste tank.

Paroxetine is used to make the antidepressant drugs, Seroxat and Paxil.

The inspection by the FDA took place last October and in a warning letter last month, it said that GSK had not fully investigated the issues at the plant.

The FDA also expressed concern about some of the equipment used at the Cork plant to manufacture the drugs' ingredients.

However, despite recalling the products, GSK has insisted that there is no risk to human health.

For more information on depression, see out Depression Clinic here